No Detail Found!

Efficacy of low-dose intravenous octreotide for 24 hours in acute variceal bleed

Author(s)
Ikram Ullah Khan Department of Gastroenterology, Hayatabad Medical Complex, Peshawar, Pakistan
Khalid Hameed Department of Gastroenterology, Hayatabad Medical Complex, Peshawar, Pakistan
Javed Iqbal Farooq Department of Gastroenterology, Hayatabad Medical Complex, Peshawar, Pakistan
ijaz M. Khan Department of Gastroenterology, Hayatabad Medical Complex, Peshawar, Pakistan
Sadiq Shah Department of Gastroenterology, Hayatabad Medical Complex, Peshawar, Pakistan
Abstract
To compare low-dose octreotide with endoscopic sclerotherapy for acute variceal bleeding. Design: A clinical trial. Place and Duration of Study: From 1995 to 2000 at PGMI, Peshawar. Subjects and Methods: Out of a total of 113 patients, 63 were allocated to low-dose octreotide (group-l) and 50 to sclerotherapy (group-ll) on simple randomization method. Octreotide was given in a dose of 25 ^g/hourfor 24 hours followed by 50 jxg subcutaneously (s/c) every 8 hours for 48 hours. Injection sclerotherapy was done by Olympus GIF 2 T 20 using absolute alcohol as sclerosing agent. Results: Overall control of bleeding and mortality was comparable in both groups over 24 hours trial period irrespective of child grading. No rebleed occurred among the patients of either group in first 24 hours. However, a statistically significant difference p < 0.05 between the two groups regarding the occurrence of rebleeding in 48 hours was observed. Conclusion: Low-dose intravenous (i/v) octreotide is as effective as injection sclerotherapy in control of acute variceal bleeding and prevention of rebleed. However, subcutaneous octreotide was not found to be as effective as sclerotherapy regarding prevention of early rebleed.
Publication Details
Page(s) 478-481
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 11, Issue: 8, Year: 2001

Request the full text from PASTIC

Keywords
Esophageal varices. Injections. Sclerotherapy. Octreotide.
References
McCormicPkA ,Kaye GL,Hobbs KEF .1992 .. Hepatology, 15 : 403-6.
Nanda R .1986 .Comparisonof two schedulesfor endoscopic sclerotherapya: prospectiverandomisedcontrolletdrial. Gut, 18 : 710-3.
Conn HO .1972 .An analysisof thecausesand preventionof thehepaticcoma (abstracGta)s. , 62 : A191.
Conn HO,Conn HO . .anagement withlactulosaend relatecdarbohydrateEsa. , : .
Huges MD .1990 .SpringerD, D'HaygereF, McIntyrNe, eta! Randomiseddouble-blind placebo-controllterdialof somatostatifnor variceal bleeding.Emergencycontroland preventionof early variceablleeding. Gastroenterology, 99 : 1388-95.
. .Comparison of somatostatinand vasopressinin bleedingoesophagealvarices. Am JGastroenterol, 99 : 1388-95.
.1991 .A prospectiverandomisedtrial comparingsomatostatibn,alloontamponadeand the combinationof both methodsin themanagementof acutevariceahlemorrhageJ. Hepatol, 13 : 78-83.
Mino G,Zuberi BF .2000 .BalochQ. Comparison of endoscopic variceaslclerotheraaplyoneand in combinationwith octreotid ein controllinagcutevaricealhemorrhage and earlyrebleedingin patientswith low-risk cirrhosisA. mJGastroenterol, 95(3) : 768-71.
Ihgrand E,Laique A,FarhadM. A .1991 .Roleof subcutaneous controlof acute varicealhemorrhage. Hepatology octreotid ein reducing earlyrebleedingin cirrhosis, 14 : 1339.
Sung JJY,Chung S,Lai CW,Cha FKL,Leung JWC .1999 .. Digestion, 60(Suppl3) : 25-34.
Jenkins SA,ShieldsR; Davis M,Elias-E, M,Ja Lee .1997 .A multicentrreandomisedtrialcomparing hemorrhageG. ut, 41(Suppl2) : 526-33.
McKee R. .1998 .A study of octreotidein oesophageal mentand outcomeof variceahlemorrhageG. Endosc, 48(4) : 442-4.
Wang S-J H,Gung HH,Lee CF,FY CF .1991 .Lu. CN etal A randomizedcontrolletdriaclomparingoctreotidaend vasopressinin thecontrolof acutevaricealhemorrhage. Hepatology, 14 : 1339.
Sheikh RA .1998 .TrudeauWL. Randomisedtriaolf octreotide forlong-termmanagementof cirrhosisaftervariceal hemorrhageG. astrointestEndosc, 48(3) : 328-30.
0

Citations

0

Downloads

68

Views